Clearwater Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Hold |
1,648
| – | – | 0.03% | 135 |
|
|
2025
Q1 | $345K | Sell |
1,648
-90
| -5% | -$18.9K | 0.03% | 133 |
|
|
2024
Q4 | $309K | Sell |
1,738
-57
| -3% | -$10.1K | 0.03% | 139 |
|
|
2024
Q3 | $354K | Buy |
1,795
+41
| +2% | +$8.1K | 0.03% | 129 |
|
|
2024
Q2 | $301K | Buy |
1,754
+16
| +0.9% | +$2.74K | 0.03% | 127 |
|
|
2024
Q1 | $316K | Sell |
1,738
-209
| -11% | -$38.1K | 0.03% | 127 |
|
|
2023
Q4 | $302K | Buy |
1,947
+88
| +5% | +$13.6K | 0.03% | 123 |
|
|
2023
Q3 | $277K | Buy |
1,859
+69
| +4% | +$10.3K | 0.03% | 115 |
|
|
2023
Q2 | $241K | Buy |
1,790
+41
| +2% | +$5.52K | 0.03% | 130 |
|
|
2023
Q1 | $279K | Sell |
1,749
-39
| -2% | -$6.22K | 0.03% | 119 |
|
|
2022
Q4 | $289K | Hold |
1,788
| – | – | 0.04% | 124 |
|
|
2022
Q3 | $240K | Hold |
1,788
| – | – | 0.03% | 137 |
|
|
2022
Q2 | $274K | Buy |
1,788
+39
| +2% | +$5.98K | 0.04% | 121 |
|
|
2022
Q1 | $284K | Buy |
+1,749
| New | +$284K | 0.03% | 137 |
|
|
2019
Q1 | – | Sell |
-2,607
| Closed | -$240K | – | 190 |
|
|
2018
Q4 | $240K | Buy |
2,607
+380
| +17% | +$35K | 0.05% | 180 |
|
|
2018
Q3 | $211K | Buy |
+2,227
| New | +$211K | 0.04% | 182 |
|
|
2018
Q2 | – | Sell |
-2,055
| Closed | -$195K | – | 181 |
|
|
2018
Q1 | $195K | Buy |
+2,055
| New | +$195K | 0.04% | 181 |
|
|
2017
Q4 | – | Sell |
-2,895
| Closed | -$263K | – | 176 |
|
|
2017
Q3 | $263K | Buy |
+2,895
| New | +$263K | 0.06% | 150 |
|